The MS Perella Weinberg Partners Tōkum long/short healthcare Ucits fund will be managed by Perella Weinberg Partners, an independent financial services firm with approximately $8.2bn assets under management.
The fund will offer access to a global long/short equity strategy focused on the healthcare industry, including biotechnologies, pharmaceuticals and companies engaged in the medical technology and services businesses.
“The launch of the MS Perella Weinberg Partners Tōkum long/short healthcare Ucits fund adds an outstanding option to gain exposure to a new sector focused strategy,” said Morgan Stanley managing director and global head of the fund and fund-linked business David Armstrong. “We look forward to our partnership with Perella Weinberg Partners to offer investors a new route to capture the evolutions of the healthcare industry.”
“The [fund] will leverage our team’s bottom-up fundamental research process to identify, within the healthcare industry’s rapidly evolving technological and regulatory frameworks, material levers impacting businesses positively or negatively over a two to four-year horizon,” said MS Perella Weinberg Partners portfolio manager Emile Westergaard.
The fund falls under Morgan Stanley’s Ucits Irish umbrella, FundLogic Alternatives.
